Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Andreas Diacon
Woman and Man Max 99 years
Andreas Diacon, MD
Update Il y a 4 ans
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)
The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral administration of PA-824 at 50, 100, 150 and 200 mg per day in adult patients with newly diagnosed...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Andreas Diacon, MD
Update Il y a 4 ans
Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB
This is the first trial in a series of clinical trials that aim to bring the concept of high dose rifampicin beyond phase II of clinical development. The safety, tolerability, extended ea...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Andreas Diacon
Update Il y a 4 ans
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)
The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral administration of TMC207 at multiple doses as determined by the rate of change of log10 colony for...
Country
South Africa
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Andreas Diacon, MD
Update Il y a 4 ans
A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI
Tuberculosis (TB) continues to be one of the most serious bacterial infections worldwide and therefore new improved diagnostic tests are needed to help doctors in diagnosing TB. The new s...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Andreas Diacon
Update Il y a 4 ans
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)
The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral administration of TMC207 alone, TMC207 with pyrazinamide, TMC207 with PA-824, PA-824 with pyrazina...
Country
South Africa
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Andreas Diacon, MD
Update Il y a 4 ans
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)
The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral administration of TMC207 plus PA-824 plus Pyrazinamide plus Clofazimine, TMC207 plus PA-824 plus P...
Country
None
organs
None
Specialty
None
Closed trial
More information